Post job

Aegerion Pharmaceuticals CEO and executives

Executive Summary. Based on our data team's research, Shehan Bharatha Dissanayake Ph.D. is the Aegerion Pharmaceuticals's CEO. Aegerion Pharmaceuticals has 200 employees, of which 4 are in a leadership position.
Work at Aegerion Pharmaceuticals?
Share your experience

Rate Aegerion Pharmaceuticals' leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Shehan Bharatha Dissanayake Ph.D.

Chief Executive Officer

Shehan Bharatha Dissanayake, PhD is a Chief Executive Officer at AEGERION PHARMACEUTICALS, INC..

Barbara Chan

VP/Chief Acctg Officer

Barbara Chan is a VP/Chief Acctg Officer at AEGERION PHARMACEUTICALS, INC.. She attended Center for Women & Business.

Bill Sasiela

Sr VP:Clinical/Chief Med Ofcr

Bill Sasiela is Senior Vice President of Clinical Development. Prior to joining ESPERION, Bill was a consultant in the pharmaceutical industry. Previously, he was the Vice President of Program Direction-Cardiovascular Metabolism at Regeneron Pharmaceuticals from 2010 to 2017.

Doreen Yianacopolus

Executive Assistant To CFO

Doreen Yianacopolus's LinkedIn

Doreen Yianacopolus is an Executive Assistant at CRISPR Therapeutics and Executive Assistant to CFO at AEGERION PHARMACEUTICALS, INC. and is based in Cambridge, Massachusetts. She has worked as Executive Assistant to CEO at Pure Communciations Inc. and Executive Assistant To Chief Financial Officer, SVB HR, Board Coordinator & Office Manager at NOVELION THERAPEUTICS INC..

Do you work at Aegerion Pharmaceuticals?

Does the leadership team provide a clear direction for Aegerion Pharmaceuticals?

Aegerion Pharmaceuticals jobs

Aegerion Pharmaceuticals executives FAQs

Zippia gives an in-depth look into the details of Aegerion Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Aegerion Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Aegerion Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Aegerion Pharmaceuticals. The data presented on this page does not represent the view of Aegerion Pharmaceuticals and its employees or that of Zippia.

Aegerion Pharmaceuticals may also be known as or be related to AEGERION PHARM, AEGERION PHARMACEUTICALS, INC., Aegerion Pharmaceuticals, Aegerion Pharmaceuticals Inc. and Aegerion Pharmaceuticals, Inc.